Tom Øresland
Tom Øresland
Editor in Chief
Medical degreee from Karolinska Institutet, Stockholm.
Basic surgical training in Karlskrona.
From 1981 at the Colorectal Unit, Sahlgrenska University Hospital, Göteborg.
Associate Professor of Surgery since 1991. Has been Secretary for the Swedish organisation for the study of IBD, chairman Swedish Gastroenterologcal Society and Swedish delegate in the European Crohn and Colitis organisation (ECCO).
Elected member of IOIBD (Int Org for the study of IBD), Since 2007 full Professor in GI surgery at the University of Oslo. Presently head Campus Ahus, Faculty of Medicine at Akershus University Hospital.
Main interest in IBD and colorectal functional problems. Published mainly in pouch surgery and related problems.
Jonas Halfvarson
Editor in Chief
Jonas Halfvarson is a Consultant Gastroenterologist specialising in IBD at Örebro University Hospital, Sweden. He graduated as MD at Uppsala University, Sweden, before training in gastroenterology at Örebro University Hospital. He undertook research with Professor Gunnar Järnerot and obtained his PhD, entitled ‘Inflammatory bowel disease in twins; Studies of genetics and environmental factors’ in 2004. Part of his PhD was done at the University of Oxford, UK with Professor Derek Jewell. Today his research focuses on biomarkers in IBD, both from a clinical and from a mechanistic perspective. He has published over 60 peer-reviewed full papers, as well as contributed to several books on IBD. He has served as vice director for the Swedish national PhD and Postdoctoral program for translational gastroenterology and heads the taskforce for genetics and pathophysiology at the Swedish Organisation for the Study of IBD. Today he is appointed Associate Professor at Örebro University and combines his time in clinical practice with his positions at the University. Dr Halfvarson was named a Rising Star in Gastroenterology at the United European Gastroenterology (UEGWeek) in 2011 and is a member of the International Organization for the study of Inflammatory Bowel Disease (IOIBD) since 2014.